STOCK TITAN

Clover Health Investments, Corp - CLOV STOCK NEWS

Welcome to our dedicated page for Clover Health Investments news (Ticker: CLOV), a resource for investors and traders seeking the latest updates and insights on Clover Health Investments stock.

Clover Health Investments, Corp. (NASDAQ: CLOV) is a physician enablement company dedicated to bringing high-quality, affordable healthcare to seniors, particularly those who have historically faced barriers to access. By leveraging its proprietary platform, Clover Assistant, Clover Health empowers physicians to make data-driven, personalized decisions, enhancing patient outcomes while reducing unnecessary costs.

Operating primarily through its Insurance and Non-Insurance segments, Clover Health offers a variety of Medicare Advantage plans, including PPO and HMO options. Through the Insurance segment, Clover Health delivers comprehensive healthcare coverage to members across multiple states. Its Non-Insurance segment participates in the ACO REACH Model, reinforcing its commitment to value-based care.

Clover Assistant aggregates patient data from across the healthcare ecosystem and provides real-time, personalized recommendations at the point of care. This tool has proven effective in improving medication adherence and managing chronic conditions, such as diabetes, high blood pressure, and high cholesterol, ultimately enhancing clinical outcomes.

Recent achievements highlight Clover Health's strategic focus and operational success. The company has demonstrated significant progress in improving medication adherence through the use of Clover Assistant. Additionally, Clover Health is targeting Adjusted EBITDA profitability for the full year of 2024, driven by strong performance in their Medicare plans and strategic investments in technology and care management.

Partnership efforts, such as those with Quartet Health, aim to enhance care delivery for underserved and high-risk patient populations through Clover's home-based care model. This initiative is part of Clover Health's broader strategy to improve health equity and provide comprehensive, coordinated care.

With a steadfast commitment to making care accessible and ensuring patients have the freedom to choose their doctors, Clover Health continues to drive innovation in healthcare. For more information about Clover Assistant, visit Clover Assistant.

Stay updated on the latest developments and strategic moves by Clover Health by following their news updates:

  • Higher fill rates result in improved performance on medication adherence quality measures in the Medicare Advantage Stars program for members where Clover Assistant was used (January 8, 2024)
  • Clover Health targeting Adjusted EBITDA profitability for the full-year 2024 (January 10, 2024)
  • Clay Thornton appointed Chief Financial Officer of Medicare Advantage division (March 7, 2024)
  • Partnership with Quartet Health to enhance home-based care delivery (February 5, 2024)
  • Counterpart Assistant now available for external payors and providers (May 29, 2024)
Rhea-AI Summary

Clover Health announced the grant of restricted stock units to its new Chief Financial Officer, Peter Kuipers. The RSUs represent the right to receive 4,228,753 shares of the Company's Class A Common Stock, with vesting over four years. This grant was made under the Company's Inducement Award Plan to attract new talent.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.06%
Tags
none
-
Rhea-AI Summary
Clover Health Investments, Corp. (NASDAQ: CLOV) will announce its first quarter 2024 financial results on May 7, 2024, followed by a conference call and webcast to discuss business and financial performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.17%
Tags
conferences earnings
-
Rhea-AI Summary
Clover Health appointed Peter Kuipers as the new Chief Financial Officer. Kuipers brings over 25 years of technology leadership experience and was recognized with the 2018 San Francisco Bay Area Public Company CFO of the Year Award. He will drive financial initiatives for profitability, growth, and new revenue streams.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.29%
Tags
management
Rhea-AI Summary
Clover Health Investments, Corp. has reached an agreement to resolve shareholder derivative actions in four jurisdictions related to its de-SPAC transaction. The Settlement involves corporate governance enhancements without any monetary payment, pending final court approval.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.71%
Tags
none
-
Rhea-AI Summary
Clover Health partners with Quartet Health to enhance care for members with serious mental illness through Clover Home Care. Quartet's expertise in behavioral health will complement Clover's home-based care model, improving outcomes for underserved patient populations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.98%
Tags
partnership
-
Rhea-AI Summary
Clover Health Investments, Corp. (CLOV) reported improved financial results for full-year 2023, with Insurance MCR at 81.2% and fourth quarter MCR at 82.4%. The company saw a net loss reduction of $126.2 million and an increase in Adjusted EBITDA by $245.7 million year-over-year. Clover issued 2024 guidance projecting Insurance MCR range of 79% - 83% and up to $20 million of Adjusted EBITDA profitability at the high end of the range.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.95%
Tags
Rhea-AI Summary
Clover Health appoints Clay Thornton as Chief Financial Officer of its Medicare Advantage division, bringing a decade of healthcare financial management experience. Thornton's track record includes significant achievements in driving financial strategies for quality outcomes and business expansion. His expertise aligns with Clover's PPO-first product strategy and state-of-the-art technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.38%
Tags
none
-
Rhea-AI Summary
Clover Health Investments, Corp. (CLOV) will report Q4 and full year 2023 financial results on March 12, 2024. A conference call and webcast will follow to discuss business and financial performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.22%
Tags
conferences earnings
-
Rhea-AI Summary
Clover Health Investments, Corp. (CLOV) granted a restricted stock unit award to a newly hired employee under the 2022 Inducement Award Plan. The employee has the right to receive 902,061 shares of the Company's Class A Common Stock, with vesting over a four-year period. This award aims to attract new talent to the company.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.73%
Tags
none
Rhea-AI Summary
Clover Health Investments, Corp. (NASDAQ: CLOV) aims for Adjusted EBITDA profitability in 2024. CEO Andrew Toy highlights the success in 2023 and plans for 2024, focusing on technology, programs, and expanding offerings. The company targets profitability through improved MA-plan performance and reduced operational spend.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.1%
Tags
none

FAQ

What is the current stock price of Clover Health Investments (CLOV)?

The current stock price of Clover Health Investments (CLOV) is $3.23 as of December 20, 2024.

What is the market cap of Clover Health Investments (CLOV)?

The market cap of Clover Health Investments (CLOV) is approximately 1.6B.

What does Clover Health do?

Clover Health is a physician enablement company that focuses on providing affordable, high-quality healthcare for seniors, particularly those on Medicare.

What is Clover Assistant?

Clover Assistant is Clover Health's proprietary software platform designed to aggregate patient data and provide real-time, personalized recommendations to physicians.

How does Clover Health generate revenue?

Clover Health primarily generates revenue through its Insurance segment by offering Medicare Advantage plans. A smaller portion comes from the Non-Insurance segment, which participates in the ACO REACH Model.

What recent achievements has Clover Health made?

Recent achievements include improving medication adherence rates through Clover Assistant and targeting Adjusted EBITDA profitability for the full year of 2024.

What types of Medicare Advantage plans does Clover Health offer?

Clover Health offers both PPO and HMO Medicare Advantage plans.

What is the significance of Clover Health's partnership with Quartet Health?

The partnership aims to enhance care for underserved and high-risk populations through Clover's home-based care model, improving both physical and behavioral health outcomes.

How does Clover Assistant benefit physicians?

Clover Assistant provides real-time, data-driven insights to physicians, aiding in early detection and management of chronic diseases, ultimately improving patient care.

What is the focus of Clover Health's Non-Insurance segment?

The Non-Insurance segment focuses on value-based care models, including participation in the ACO REACH Model.

What are Clover Health's future goals?

Clover Health aims to achieve Adjusted EBITDA profitability for the full year of 2024 and expand the reach of Clover Assistant through its Counterpart Assistant initiative.

How does Clover Health improve healthcare accessibility?

Clover Health is committed to making healthcare accessible by offering affordable Medicare Advantage plans and ensuring patients can choose their preferred doctors.

Clover Health Investments, Corp

Nasdaq:CLOV

CLOV Rankings

CLOV Stock Data

1.59B
388.41M
5.33%
20.16%
3.28%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States of America
FRANKLIN